An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.
Jemperli is already approved on the NHS for women with some types of advanced or recurrent womb cancer. “These results bring us one step closer to understanding the potential of dostarlimab in this curative-intent setting for patients with dMMR locally advanced rectal cancer.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Immunotherapy significantly increases the number of patients free from bowel cancer: Clinical trialAn immunotherapy drug given before surgery instead of chemotherapy meant that over ten times more patients with a certain genetic profile were cancer-free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.
Source: medical_xpress - 🏆 101. / 51 Read more »
Study examines the cost-effectiveness of a targeted immunotherapy for lung cancerMany countries with national healthcare systems or payers such as insurance companies use cost-effectiveness analyses to decide whether to cover new medicines, balancing treatment costs with potential health benefits.
Source: NewsMedical - 🏆 19. / 71 Read more »
New immunotherapy could treat cancer in the boneA new type of immunotherapy, developed by UCL researchers, has shown promising preclinical results against a bone cancer called osteosarcoma, as part of a study in mice.
Source: medical_xpress - 🏆 101. / 51 Read more »
Study reveals circadian clock can be leveraged to enhance cancer immunotherapyA multidisciplinary research team at the University of California, Irvine has revealed that the circadian clock—the biological pacemaker that governs daily rhythms in physiological processes, including immune functions—can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy.
Source: medical_xpress - 🏆 101. / 51 Read more »
New subset of T cells may enhance cancer immunotherapyA team of cancer researchers, led by the University of Houston, has discovered a new subset of T cells that may improve the outcome for patients treated with T-cell therapies.
Source: NewsMedical - 🏆 19. / 71 Read more »
Immunotherapy-chemotherapy combo boosts survival for patients with metastatic colorectal cancerA study led by UCLA Health Jonsson Comprehensive Cancer Center researchers found that using a combination of experimental immunotherapy drugs with chemotherapy significantly improves progression-free survival and overall survival for patients with metastatic colorectal cancer who have previously undergone standard chemotherapy treatment when...
Source: NewsMedical - 🏆 19. / 71 Read more »